Literature DB >> 16514489

Electrooculography after photodynamic therapy.

Ayse Oner1, Sarper Karakucuk, Ertugrul Mirza, Kuddusi Erkilic.   

Abstract

PURPOSE: To evaluate the changes in electrooculography (EOG) after photodynamic therapy (PDT).
METHODS: Thirty-eight eyes of 38 patients (21 males, 17 females) with choroidal neovascularization secondary to age related macular degeneration were included in this study. Standart PDT with verteporfin was performed on each patient. Serial EOG recordings were performed before, 1 week, and 1 month after PDT.
RESULTS: Mean age of the patients was 69.8+/-9.7 years (range 56 and 90 years). Seven days after PDT the visual acuity improved in 17 eyes, remained unchanged in 16 eyes and deteriorated in 5 eyes. One month after PDT the visual acuity findings were the same as the first week. New hemorrhages were seen in three eyes in the first week after PDT and visual acuity was decreased in those patients. No other patient complained of ocular and systemic adverse events. There was a statistically significant reduction in the Arden ratio of the EOG 1 week after PDT and the reduction persisted in the first month recordings.
CONCLUSIONS: The reduction in Arden ratio of EOG findings may indicate that retina pigment epithelium function could be affected after PDT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514489     DOI: 10.1007/s10633-005-4410-4

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  13 in total

1.  Photodynamic therapy for choroidal neovascularization associated with pattern dystrophy.

Authors:  Maurizio Battaglia Parodi; Stefano Da Pozzo; Giuseppe Ravalico
Journal:  Retina       Date:  2003-04       Impact factor: 4.256

2.  Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization.

Authors:  Adam H Rogers; Adam Martidis; Paul B Greenberg; Carmen A Puliafito
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

Review 3.  Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration.

Authors:  U Schmidt-Erfurth; T Hasan
Journal:  Surv Ophthalmol       Date:  2000 Nov-Dec       Impact factor: 6.048

4.  Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration.

Authors:  R W Flower; C von Kerczek; L Zhu; A Ernest; C Eggleton; L D Topoleski
Journal:  Am J Ophthalmol       Date:  2001-07       Impact factor: 5.258

5.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

6.  Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision.

Authors:  M F Marmor; E Zrenner
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

7.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

8.  Sequence of early vascular events after photodynamic therapy.

Authors:  Stephan Michels; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

9.  Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.

Authors:  Darius M Moshfeghi; Peter K Kaiser; Hans E Grossniklaus; Paul Sternberg; Jonathan E Sears; Mark W Johnson; Norman Ratliff; Andre Branco; Mark S Blumenkranz; Hilel Lewis
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

10.  Concentric retinal pigment epithelium atrophy after a single photodynamic therapy.

Authors:  Joachim Wachtlin; Tim Behme; Heinrich Heimann; Ulrich Kellner; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-07       Impact factor: 3.117

View more
  1 in total

1.  Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.

Authors:  George D Tsakonas; Athanasios I Kotsolis; Chrysanthi Koutsandrea; Ilias Georgalas; Dimitrios Papaconstantinou; Ioannis D Ladas
Journal:  Clin Ophthalmol       Date:  2012-10-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.